Position in MRNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$61,841,741
+$23,699,020 QoQ
Shares Held
883,075
+17.6% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 777 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. MRNA ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,841,741 | 883,075 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $38,142,721 | 750,841 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $27,631,244 | 936,970 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $25,862,518 | 1,001,259 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $39,347,864 | 1,426,164 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $64,400,511 | 2,271,623 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $89,693,090 | 2,157,121 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $139,512,235 | 2,087,569 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $246,713,931 | 2,077,591 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $249,106,908 | 2,337,715 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $235,106,959 | 2,364,072 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $244,980,536 | 2,371,774 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $296,205,822 | 2,437,908 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $360,402,499 | 2,346,676 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $423,239,503 | 2,356,305 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $289,572,255 | 2,448,814 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $366,954,651 | 2,568,811 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $408,670,140 | 2,372,403 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $562,282,512 | 2,213,885 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $825,040,545 | 2,143,742 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $441,553,032 | 1,879,109 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $201,668,499 | 1,540,042 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $161,124,392 | 1,542,303 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $104,661,393 | 1,479,313 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $61,023,064 | 950,367 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,236,066 | 174,827 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||